Syk and tired of current chronic GVHD therapies.

Blood ·Vol. 125 ·No. 26 ·2015-09-07

Fowler Daniel H, Pavletic Steven Z

Abstract

In this issue of Blood, Flynn et al1 provide key data that lend further support to the development of clinical trials of spleen tyrosine kinase (Syk) inhibition for more effective chronic graft-versus-host disease (cGVHD) treatment.

Article Info

Journal

Blood

Abbr.

Blood

ISSN

0006-4971

Published

2015-09-07

Indexed

2015-06-26

Updated

2015-11-10

Language

English

Country/Region

United States

NLM ID

7603509

External Links

PubMed source View journal details

Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.

Business Email

E-mail: [email protected]